Thompson Siegel & Walmsley’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-752
| Closed | -$73K | – | 507 |
|
2023
Q4 | $73K | Hold |
752
| – | – | ﹤0.01% | 404 |
|
2023
Q3 | $91K | Hold |
752
| – | – | ﹤0.01% | 388 |
|
2023
Q2 | $86K | Hold |
752
| – | – | ﹤0.01% | 401 |
|
2023
Q1 | $104K | Hold |
752
| – | – | ﹤0.01% | 393 |
|
2022
Q4 | $97K | Hold |
752
| – | – | ﹤0.01% | 389 |
|
2022
Q3 | $83K | Hold |
752
| – | – | ﹤0.01% | 396 |
|
2022
Q2 | $56K | Hold |
752
| – | – | ﹤0.01% | 407 |
|
2022
Q1 | $59K | Hold |
752
| – | – | ﹤0.01% | 451 |
|
2021
Q4 | $68K | Hold |
752
| – | – | ﹤0.01% | 461 |
|
2021
Q3 | $70K | Sell |
752
-248
| -25% | -$23.1K | ﹤0.01% | 451 |
|
2021
Q2 | $78K | Hold |
1,000
| – | – | ﹤0.01% | 452 |
|
2021
Q1 | $75K | Hold |
1,000
| – | – | ﹤0.01% | 437 |
|
2020
Q4 | $170K | Hold |
1,000
| – | – | ﹤0.01% | 345 |
|
2020
Q3 | $140K | Hold |
1,000
| – | – | ﹤0.01% | 346 |
|
2020
Q2 | $160K | Hold |
1,000
| – | – | ﹤0.01% | 341 |
|
2020
Q1 | $98K | Hold |
1,000
| – | – | ﹤0.01% | 360 |
|
2019
Q4 | $129K | Buy |
+1,000
| New | +$129K | ﹤0.01% | 407 |
|